Pfizer's Upjohn has merged with Mylan to form Viatris
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Pfizer's Upjohn has merged with Mylan to form Viatris sits in the top decile of US sponsors by registered trial count (#186 of 15,742 sponsors by registered trial count).
Pfizer's Upjohn has merged with Mylan to form Viatris: 158 sponsored US clinical trials, none currently recruiting.
Pfizer's Upjohn has merged with Mylan to form Viatris sponsors 158 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 138 completed. 128 of these trials are in Phase 3-4 (later-stage) and 24 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 3 trials.
Top-decile sponsor footprint
Pfizer's Upjohn has merged with Mylan to form Viatris ranks in the top decile of sponsors by registered trial count (#186 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
138 of 158 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
158 total, page 2 of 4
A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.
NCT00716859
Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet
NCT00917644
A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.
NCT00638742
To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
NCT00430716
Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures
NCT00596466
Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients
NCT00676403
Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo
NCT00631696
Bioavailability Study for New Atorvastatin Formulation
NCT00844376
Celebrex In Acute Gouty Arthritis Study
NCT00549549
Taste Test of a New Formulation of Sildenafil (Revatio)
NCT00768573
Surgical Pain After Inguinal Hernia Repair (SPAIHR)
NCT00551135
A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain
NCT00662558
Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
NCT00483548
Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
NCT00524030
Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy
NCT00468845
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
NCT00448916
Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement
NCT00442546
Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures
NCT00437281
A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury
NCT00407745
A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk
NCT00412113
Evaluation of Atorvastatin Treatment on Carotid Plaque.
NCT00343655
Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat
NCT00402987
Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).
NCT00413010
Effects Of Detrol LA On Memory And Cognition In Elderly Population
NCT00411437
A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer
NCT00381095
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
NCT00406315
Celebrex Total Knee Arthroplasty Study
NCT00359151
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
NCT00346216
GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)
NCT00373685
Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension
NCT00323297
Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
NCT00585312
A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment
NCT00659100
Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
NCT00351611
A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.
NCT00343200
Caduet in an Untreated Subject Population
NCT00332761
Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
NCT00265382
3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
NCT00312494
Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia
NCT00257192
A Polysomnographic Study Of Single-Dose Gabapentin In Transient Insomnia
NCT00674752
A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines
NCT00232180
Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
NCT00265330
Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.
NCT00290901
Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy
NCT00264875
A Safety Study Of Pregabalin In Fibromyalgia
NCT00282997
A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.
NCT00282464
Study of Celecoxib Bioavailability in Healthy Subjects
NCT00296127
Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
NCT00257166
Detrol LA In Men With Overactive Bladder.
NCT00282932
A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma
NCT00277498
Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
NCT00280566
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 19 |
| Phase 2 | 5 |
| Phase 3 | 75 |
| Phase 4 | 53 |
How the Pfizer's Upjohn has merged with Mylan to form Viatris archive is shaped
158 indexed studies, none listed as recruiting (0% open); 138 completed (87%).
Phase mix: 128 late (III/IV) vs 24 early (I/II) (later-stage heavy).
Top condition: Healthy (3 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Pfizer's Upjohn has merged with Mylan to form Viatris: archived-pipeline peers nationwide
Peers matched on 158 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Pfizer's Upjohn has merged with Mylan to form Viatris sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 158 archived trials
- Galderma R&D · 158 trials · 4% recruiting
- Ann & Robert H Lurie Children's Hospital of Chicago · 159 trials · 19% recruiting
- University of South Carolina · 157 trials · 19% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Pfizer's Upjohn has merged with Mylan to form Viatris page
158 registered trials is a research-attention snapshot, not an endorsement of Pfizer's Upjohn has merged with Mylan to form Viatris or any single study.
- None of Pfizer's Upjohn has merged with Mylan to form Viatris's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Healthy is the condition Pfizer's Upjohn has merged with Mylan to form Viatris studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Pfizer's Upjohn has merged with Mylan to form Viatris pipeline card: 158 registered trials from official public datasets.Report a data error.